Clinical Trial Update: A Preliminary Clinical Study on the Efficacy of Cyclophosphamide and Sirolimus Combined With VIC-1911 in Preventing Graft-versus-Host Disease After Haploidentical Stem Cell Transplantation in Children [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the efficacy of combining cyclophosphamide, sirolimus, and VIC-1911 to prevent graft-versus-host disease after haploidentical stem cell…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Sirolimus (Sirolimus)
• VIC-1911

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: GVHD (Acute or Chronic) | Phase 1 | Status: NOT_YET_RECRUITING